Simulations Plus, Inc. $SLP Shares Purchased by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC increased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 46.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 392,840 shares of the technology company’s stock after buying an additional 124,264 shares during the period. Stephens Investment Management Group LLC’s holdings in Simulations Plus were worth $5,920,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SLP. Tributary Capital Management LLC boosted its stake in shares of Simulations Plus by 214.7% during the 3rd quarter. Tributary Capital Management LLC now owns 1,136,980 shares of the technology company’s stock worth $17,134,000 after acquiring an additional 775,704 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in Simulations Plus by 25.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company’s stock worth $15,277,000 after purchasing an additional 176,747 shares during the period. Geode Capital Management LLC boosted its position in Simulations Plus by 3.1% during the second quarter. Geode Capital Management LLC now owns 397,851 shares of the technology company’s stock worth $6,943,000 after purchasing an additional 12,003 shares in the last quarter. First Light Asset Management LLC acquired a new stake in Simulations Plus in the second quarter valued at approximately $6,232,000. Finally, Bank of America Corp DE increased its position in shares of Simulations Plus by 3.3% in the second quarter. Bank of America Corp DE now owns 209,218 shares of the technology company’s stock valued at $3,651,000 after buying an additional 6,671 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Trading Up 0.3%

SLP stock opened at $20.33 on Friday. The firm has a 50-day moving average of $18.52 and a two-hundred day moving average of $16.33. Simulations Plus, Inc. has a 12 month low of $12.39 and a 12 month high of $37.67. The company has a market cap of $409.65 million, a price-to-earnings ratio of -6.35 and a beta of 1.09.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.05). Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.The company had revenue of $18.42 million for the quarter, compared to analyst estimates of $18.05 million. During the same quarter in the prior year, the firm earned $0.17 earnings per share. As a group, equities analysts forecast that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on SLP. TD Cowen increased their target price on Simulations Plus from $16.00 to $19.00 and gave the company a “hold” rating in a research report on Thursday, January 8th. Cowen restated a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. BTIG Research lowered shares of Simulations Plus from a “buy” rating to a “neutral” rating in a research report on Thursday, December 18th. Citigroup reissued a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Simulations Plus in a research note on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $25.00.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.